Prevalence and predictors of Potentially Inappropriate Psychotropic Medication in older adults with psychiatric illness

2021 ◽  
Vol 66 ◽  
pp. 102872
Author(s):  
Rishabh Sharma ◽  
Parveen Bansal ◽  
Arvind Sharma ◽  
Manik Chhabra ◽  
Rakesh Kumar ◽  
...  
2016 ◽  
Vol 28 (10) ◽  
pp. 1587-1588 ◽  
Author(s):  
Donovan T. Maust

The use of psychotropic medication among persons with dementia (PWD) both in nursing home (Wetzels et al., 2011) and community settings (Maust et al., 2016) far exceeds what might be expected based on their limited evidence for benefit (Kales et al., 2015). This relatively high use persists despite years of evidence about the potential harms associated with their use in older adults generally and PWD in particular (e.g. Wang et al., 2001; Schneider et al., 2005). However, the solution to relatively high psychotropic use is not to end all psychotropic use, as there are individual patients for whom use of such medication is appropriate. For example, a policy that defines all antipsychotic use as inappropriate may simply lead to increased use of alternatives with even less evidence of benefit, as suggested by the response to antipsychotics’ black box warning in the United States (Kales et al., 2011).


2015 ◽  
Vol 27 (10) ◽  
pp. 1749-1750 ◽  
Author(s):  
Delphine Raucher-Chéné ◽  
Nicolas Hoertel ◽  
Céline Béra-Potelle ◽  
Sarah Terrien ◽  
Sarah Barrière ◽  
...  

The increased life expectancy in people with severe and persistent psychiatric illness, such as schizophrenia or bipolar disorder, has been predicted to substantially affect mental healthcare system (Bartels et al., 2002) that must adapt to meet the needs of older adults (Jeste et al., 1999). Development of specialized geriatric psychiatry services is thus needed.


2018 ◽  
pp. 163-201
Author(s):  
Ana Hategan ◽  
James A. Bourgeois ◽  
Tracy Cheng ◽  
Julie Young

2011 ◽  
Vol 15 (5) ◽  
pp. 618-629 ◽  
Author(s):  
SangNam Ahn ◽  
Ming Tai-Seale ◽  
Charles Huber Jr ◽  
Matthew L. Smith ◽  
Marcia G. Ory

Pharmacy ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. 74
Author(s):  
Mohsen Bazargan ◽  
Sharon Cobb ◽  
Cheryl Wisseh ◽  
Shervin Assari

African-American older adults, particularly those who live in economically deprived areas, are less likely to receive pain and psychotropic medications, compared to Whites. This study explored the link between social, behavioral, and health correlates of pain and psychotropic medication use in a sample of economically disadvantaged African-American older adults. This community-based study recruited 740 African-American older adults who were 55+ yeas-old in economically disadvantaged areas of South Los Angeles. Opioid-based and psychotropic medications were the outcome variables. Gender, age, living arrangement, socioeconomic status (educational attainment and financial strain), continuity of medical care, health management organization membership, sleeping disorder/insomnia, arthritis, back pain, pain severity, self-rated health, depressive symptoms, and major chronic conditions were the explanatory variables. Logistic regression was used for data analyses. Arthritis, back pain, severe pain, and poor self-rated health were associated with opioid-based medications. Pain severity and depressive symptoms were correlated with psychotropic medication. Among African-American older adults, arthritis, back pain, poor self-rated health, and severe pain increase the chance of opioid-based and psychotropic medication. Future research should test factors that can reduce inappropriate and appropriate use and prescription of opioid-based and psychotropic medication among economically disadvantaged African-American older adults.


2017 ◽  
Vol 23 ◽  
pp. 32
Author(s):  
C. Janney ◽  
K. Carmichael ◽  
C. Wigg ◽  
D. Jupiter ◽  
J. Goodrum

Sign in / Sign up

Export Citation Format

Share Document